Clinical Trial Update: Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of TAK-438 (vonoprazan) for maintaining healing in erosive esophagitis has completed, reporting safety data from extended use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• TAK-438 (vonoprazan) (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED